#USA #New York #Securities Fraud #Berger Montague #LifeMD

Investor Alert: Class Action Lawsuit Against LifeMD, Inc.

Berger Montague, a prominent national plaintiffs' law firm, has recently announced a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD), a company specializing in virtual medical services and prescription delivery. This lawsuit is significant for investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025, during which the company allegedly misrepresented key aspects of its financial standing and operational challenges.

Details of the Case

The lawsuit alleges that LifeMD overstated its competitive position within the healthcare technology sector and issued overly optimistic financial predictions for 2025. Specifically, the complaint accuses the company of neglecting to disclose increasing customer acquisition costs associated with its RexMD platform—an integral service for obtaining prescriptions—and providing misleading communications regarding its promotional strategies for anti-obesity medications like Wegovy and Zepbound. Investors faced considerable losses when the market adjusted to reflect the actual circumstances surrounding LifeMD's financial health, leading to questions about the credibility of its earlier statements.

Berger Montague invites potentially affected shareholders to take action—the law firm is urging anyone who acquired LifeMD shares within the specified period to initiate conversations about their rights and consider becoming lead plaintiffs in this class action. The deadline for expressing interest in this opportunity is set for October 27, 2025. Interested parties can obtain more information about their rights through the law firm’s communication channels.

Company Background

Headquartered in New York City, LifeMD aims to provide seamless access to healthcare through its innovative digital platform. By offering virtual consultations and medication delivery, it caters to a wide range of medical needs while positioning itself as a leader in the telehealth industry. However, the allegations in the lawsuit suggest a gap between the company’s presentation and its actual performance metrics, prompting scrutiny from legal representatives and the investment community alike.

Berger Montague has developed a reputation for championing investor rights and leading class action lawsuits for over five decades. Their extensive experience positions them well to navigate the complexities of securities fraud claims, and they are known for their commitment to representing both individuals and institutional investors in such matters.

Next Steps for Affected Investors

Investors who suspect they may have been misled by LifeMD's statements during the class period have a clear path forward.

• - To learn more about their rights and gather additional details about the lawsuit, investors are encouraged to contact Berger Montague directly. Key contacts at the firm include Andrew Abramowitz and Caitlin Adorni, who can provide personalized assistance and advice based on individual circumstances.
• - For those interested in becoming lead plaintiffs, ensuring timely communication with the law firm before the October deadline is crucial to ensuring their voices and experiences are adequately represented.

This lawsuit serves as a reminder of the importance of due diligence and transparent communication in the ever-evolving financial landscape. As the series of events continues to unfold, impacted investors should remain vigilant and informed about their rights and options concerning this case against LifeMD, Inc.

Berger Montague is ready to advocate for those affected, ensuring that shareholder rights are safeguarded amidst the complexities of corporate governance and market dynamics.